Neurotech Pharmaceuticals Lands $15,000,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0a9b82f3-4cab-4d10-8cbb-d633cc6f69a4&Preview=1 -
Date
10/22/2008 -
Company Name
Neurotech Pharmaceuticals -
Mailing Address
6 Blackstone Valley Place Lincoln, RI 02865 -
Company Description
Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new medical therapies are the largest market opportunity in ophthalmology. -
Website
http://www.neurotechusa.com
-
Transaction Type
Venture Equity -
Transaction Amount
$15,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
